Frankfurt - Delayed Quote EUR
Akeso, Inc. (4RY.F)
9.40
+0.05
+(0.53%)
At close: May 16 at 7:07:06 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-527,615
-527,615
2,467,773
-1,240,413
-1,001,238
Investing Cash Flow
-1,522,863
-1,522,863
-3,997,250
-889,747
-579,585
Financing Cash Flow
3,389,271
3,389,271
960,891
1,485,850
1,586,555
End Cash Position
2,915,742
2,915,742
1,542,313
2,092,388
2,641,625
Capital Expenditure
-593,734
-593,734
-879,490
-802,498
-716,111
Issuance of Capital Stock
2,851,133
2,851,133
0
500,466
992,028
Issuance of Debt
1,318,716
1,318,716
1,473,782
1,050,487
736,143
Repayment of Debt
-356,794
-356,794
-374,847
-45,448
-90,760
Repurchase of Capital Stock
--
--
--
0
-51,718
Free Cash Flow
-1,121,349
-1,121,349
1,588,283
-2,042,911
-1,717,349
12/31/2021 - 4/28/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0060
+445.45%
AAPG Ascentage Pharma Group Internat
22.65
+0.13%
ADAG Adagene Inc.
1.7700
-2.75%
ACTU Actuate Therapeutics, Inc. Common stock
10.55
+8.09%
1801.HK INNOVENT BIO
51.000
+2.10%
ADIL Adial Pharmaceuticals, Inc.
0.6578
-0.33%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+3.73%
ACLX Arcellx, Inc.
58.78
+0.56%
TRVI Trevi Therapeutics, Inc.
6.50
+5.01%
ACRS Aclaris Therapeutics, Inc.
1.3100
+7.38%